ESR1 and triple-negative breast carcinoma: Furthermore, specific MDSCs subtypes have distinct clinical associations: polymorphonuclear MDSCs (PMN-MDSCs) with triple-negative breast cancer, and monocytic MDSCs (M-MDSCs) with estrogen receptor (ER)-negative status and liver or bone metastasis [3].